These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22913901)

  • 21. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
    Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
    Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
    Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
    Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin therapy and exercise.
    Kourtoglou GI
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S73-7. PubMed ID: 21864755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, hepatic metabolism and disease.
    Edmison JM; Kalhan SC; McCullough AJ
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy.
    Gulve EA
    Phys Ther; 2008 Nov; 88(11):1297-321. PubMed ID: 18801852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease.
    Paredes AH; Torres DM; Harrison SA
    Clin Liver Dis; 2012 May; 16(2):397-419. PubMed ID: 22541706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.
    Morita Y; Ueno T; Sasaki N; Tateishi Y; Nagata E; Kage M; Sata M
    Hepatogastroenterology; 2005; 52(65):1338-43. PubMed ID: 16201069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis].
    Kalmykova ZA; Kononenko IV; Mayorov AY
    Ter Arkh; 2019 Oct; 91(10):106-111. PubMed ID: 32598639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes co-existing with chronic liver disease: clinical features and response to therapy.
    Chuhwak EK; Pam SD
    Niger J Med; 2007; 16(2):156-60. PubMed ID: 17694770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Mellitus: Management of Gastrointestinal Complications.
    Careyva B; Stello B
    Am Fam Physician; 2016 Dec; 94(12):980-986. PubMed ID: 28075092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expert Opinion by Clinicians on the Use of Insulin Therapy in People with Hepatic Impairment.
    Chawla P; Shunmugavelu M; Jaggi S; Asirvatham AJ; Basu D; Shah T; Farishta F; Das AK
    J Assoc Physicians India; 2023 Feb; 71(2):11-12. PubMed ID: 37354474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of diabetes mellitus of patients with chronic liver disease.
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Maldonado-Garza HJ; Villarreal-Pérez JZ
    Ann Hepatol; 2015; 14(6):780-8. PubMed ID: 26436350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.
    Iyengar R; Franzese J; Gianchandani R
    Curr Diab Rep; 2018 Aug; 18(10):75. PubMed ID: 30112652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic liver diseases and diabetes].
    Jaafar J; de Kalbermatten B; Philippe J; Scheen A; Jornayvaz FR
    Rev Med Suisse; 2014 Jun; 10(433):1254, 1256-60. PubMed ID: 25004772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.